Purchase Order 75N93021P00537

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $49,684.25 firm fixed price delivery order to Illumina, Inc. for a NEXTSEQ 500/550 HIGH OUTPUT KIT V2.5 (300 CYCLES). The place of performance is San Diego, California. Illumina will provide the sequencing kit to support genomic analysis at the NIH Clinical Center under this contract with no set-aside designation. As the sole manufacturer of the NextSeq sequencing platform, Illumina is uniquely...

This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is valued at $21,302.82 and has an ultimate completion date of September 30, 2024. It is for the provision of NextSeq 500/550 High Output Kit v2.5 (300 cycles), which supports genomic sequencing and analysis. Illumina has a history of providing sequencing instruments, consumables, and services to...

This is a firm fixed-price delivery order awarded by the Department of Agriculture's Agricultural Research Service to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and consumables. The order is for NEXTSEQ 500/550 HI OUTPUT KITV2.5 (300CY) and other laboratory equipment and consumables, with a potential value of $313,117.42 and a completion date of May 25, 2025. No set-aside was used for this award. Illumina has a history of providing sequencing systems and related...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the procurement of a NEXTSEQ 500 HIGH OUTPUT KIT (300 CYCLES) with a ceiling value of $77,520.00. The award was made on August 14, 2014 with a period of performance ending September 30, 2017. This award does not have a set-aside designation. Illumina, Inc. is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has a history of...

This is a firm fixed-price delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $13,477.18 order is for the TruSeq SBS Kit v3-HS (200 cycles), a consumable used with Illumina's sequencing platforms. The award has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and support services to various federal...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analytical instruments and reagents, for the delivery of NEXTSEQ 500/550 HIGH OUTPUT KIT V2.5 (300 CYCLES) with a potential value of $19,975.20. The contract has a performance period through May 30, 2024 and was awarded on April 19, 2024 without any set-aside designation. Illumina has...

This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genetic and genomic analysis instrumentation and reagents. The contract is for the delivery of NEXTSEQ 500/550 HIGH OUTPUT KIT V2.5 (300 CYCLES) at a ceiling value of $24,942.05 with a final completion date of August 29, 2024. This award does not utilize any set-aside designations. Illumina has previously been awarded prime contracts and subcontracts...

This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $24,942.05 contract is for the provision of NextSeq 500/550 High Output Kits v2.5 (300 cycles), which are consumables used with Illumina's NextSeq sequencing platforms. The award has no set-aside designation and the ultimate completion date is August 25, 2024. Illumina has a history of providing...

This $7,086 firm-fixed price purchase order was awarded by the Southeast Area of the U.S. government's civilian agency to Azenta US Inc., doing business as Brooks Life Sciences Inc. The contract is for DNA sequencing of PCR products using Sanger sequencing. The contractor must be able to sequence samples in 96-well plate format as well as single tubes, provide a 24-hour turnaround time, and offer pricing of approximately $6 per base for tubes and $4 per base for plates. The contract does not...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents, for the provision of NEXTSEQ 500/550 HIGH OUTPUT KIT V2.5 (300 CYCLES). The $24,969.00 award has a completion date of May 9, 2024. Illumina is a for-profit organization that has previously held prime federal contracts and sub-grants with agencies such as the National Institutes of...